Search Results - "Tachibana, Takayoshi"

Immuno Chemotherapy and CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia by Tachibana, Takayoshi

Get more information

A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation by Izumi, Akihiko, Tachibana, Takayoshi, Ando, Taiki, Tanaka, Masatsugu, Kanamori, Heiwa, Nakajima, Hideaki

“…This single-center retrospective study was performed in consecutive patients with acute lymphoblastic leukemia who relapsed after allogeneic hematopoietic cell…”
Get full text

Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation by Tachibana, Takayoshi, Tanaka, Masatsugu, Hagihara, Maki, Fujimaki, Katsumichi, Kanamori, Heiwa, Nakajima, Hideaki

“…Outcomes in patients with acute lymphoblastic leukemia (ALL) who experience relapse after allogeneic hematopoietic cell transplantation (HCT) are…”
Get full text

Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients by Harada, Ibuki, Sasaki, Haruka, Murakami, Koichi, Nishiyama, Akira, Nakabayashi, Jun, Ichino, Motohide, Miyazaki, Takuya, Kumagai, Ken, Matsumoto, Kenji, Hagihara, Maki, Kawase, Wataru, Tachibana, Takayoshi, Tanaka, Masatsugu, Saito, Tomoyuki, Kanamori, Heiwa, Fujita, Hiroyuki, Fujisawa, Shin, Nakajima, Hideaki, Tamura, Tomohiko

“…Chronic myeloid leukemia (CML) is a form of myeloproliferative neoplasm caused by the oncogenic tyrosine kinase BCR-ABL. Although tyrosine kinase inhibitors…”
Get full text

Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib by Tachibana, Takayoshi, Tanaka, Masatsugu, Noguchi, Yuma, Najima, Yuho, Sadato, Daichi, Harada, Yuka, Tamai, Yotaro, Doki, Noriko, Nakajima, Hideaki

“…The outcomes of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) resistant to new drugs such as tyrosine kinase inhibitors,…”
Get full text

Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia by Hirose, Natsuki, Tachibana, Takayoshi, Izumi, Akihiko, Sato, Shuku, Tadera, Noriyuki, Tamai, Yotaro, Kanamori, Heiwa, Tanaka, Masatsugu, Nakajima, Hideaki

“…This single-center retrospective study was performed to evaluate the safety and efficacy of FMS-like tyrosine kinase 3 (FLT3) inhibitors before and after…”
Get full text

Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia by Tachibana, Takayoshi, Koyama, Satoshi, Andou, Taiki, Ishiyama, Yasufumi, Tanaka, Masatsugu, Nakajima, Hideaki, Kanamori, Heiwa

“…A single-center retrospective study was performed with consecutive patients who received salvage therapy using ponatinib for the aim of allogeneic…”
Get full text

Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation—a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT by Akahoshi, Yu, Arai, Yasuyuki, Nishiwaki, Satoshi, Tachibana, Takayoshi, Shinohara, Akihito, Doki, Noriko, Uchida, Naoyuki, Tanaka, Masatsugu, Kanda, Yoshinobu, Shiratori, Souichi, Ozawa, Yukiyasu, Shono, Katsuhiro, Katayama, Yuta, Tanaka, Junji, Fukuda, Takahiro, Atsuta, Yoshiko, Kako, Shinichi

“…White blood cell count (WBC) at diagnosis is the conventional prognostic factor in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL)…”
Get full text

Impact of bone marrow nucleated cell subfractions on transplant outcomes in patients with acute lymphoblastic leukemia by Nukui, Jun, Tachibana, Takayoshi, Miyazaki, Takuya, Tanaka, Masatsugu, Matsumoto, Kenji, Ishii, Yoshimi, Numata, Ayumi, Nakajima, Yuki, Matsumura, Ayako, Suzuki, Taisei, Izumi, Akihiko, Hirose, Natsuki, Yamamoto, Koji, Hagihara, Maki, Fujisawa, Shin, Nakajima, Hideaki

“…Our previous study showed that a high pre-transplant nucleated cell count in the bone marrow is associated with increased non-relapse mortality (NRM) and…”
Get full text

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study by Najima, Yuho, Tachibana, Takayoshi, Takeda, Yusuke, Koda, Yuya, Aoyama, Yasuhisa, Toya, Takashi, Igarashi, Aiko, Tanaka, Masatsugu, Sakaida, Emiko, Abe, Ryohei, Onizuka, Makoto, Kobayashi, Takeshi, Doki, Noriko, Ohashi, Kazuteru, Kanamori, Heiwa, Ishizaki, Takuma, Yokota, Akira, Morita, Satoshi, Okamoto, Shinichiro, Kanda, Yoshinobu

“…This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT)…”
Get full text

Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin by Kanda, Junya, Ando, Toshihiko, Kimura, Shun-ichi, Fujiwara, Shin-ichiro, Imada, Kazunori, Fujisawa, Shin, Tachibana, Takayoshi, Atsuta, Yoshiko, Kanda, Yoshinobu

“…Hematopoietic stem cell transplantation (HSCT) from a related donor with an human leukocyte antigen (HLA) 1-antigen mismatch without in vivo T cell depletion…”
Get full text

Detection of Mycobacterium tuberculosis-derived DNA in circulating cell-free DNA from a patient with disseminated infection using digital PCR by Yamamoto, Masaki, Ushio, Ryota, Watanabe, Hiroki, Tachibana, Takayoshi, Tanaka, Masatsugu, Yokose, Tomoyuki, Tsukiji, Jun, Nakajima, Hideaki, Kaneko, Takeshi

“…•A case of disseminated Mycobacterium tuberculosis (MTB) infection after hematopoietic stem cell transplantation is reported.•Circulating cell-free DNA of the…”
Get full text

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis by Tachibana, Takayoshi, Kanda, Junya, Ishizaki, Takuma, Najima, Yuho, Tanaka, Masatsugu, Doki, Noriko, Fujiwara, Shin-ichiro, Kimura, Shun-ichi, Onizuka, Makoto, Takahashi, Satoshi, Saito, Takeshi, Mori, Takehiko, Fujisawa, Shin, Sakaida, Emiko, Matsumoto, Kenji, Aotsuka, Nobuyuki, Goto, Moritaka, Watanabe, Reiko, Shono, Katsuhiro, Usuki, Kensuke, Tsukada, Nobuhiro, Kanamori, Heiwa, Kanda, Yoshinobu, Okamoto, Shinichiro

“…A multicenter retrospective study was performed to explore a prognostic scoring index in order to identify a population who are least likely to benefit from…”
Get full text

Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation by Shiratori, Souichi, Sugita, Junichi, Ota, Shuichi, Kasahara, Senji, Ishikawa, Jun, Tachibana, Takayoshi, Hayashi, Yoshiki, Yoshimoto, Goichi, Eto, Tetsuya, Iwasaki, Hiromi, Harada, Mine, Matsuo, Keitaro, Teshima, Takanori

“…Allogeneic peripheral blood stem cell transplantation (PBSCT) is associated with an increased risk of severe acute and chronic graft-versus-host disease (GVHD)…”
Get full text

Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia by Ando, Taiki, Fujisawa, Shin, Teshigawara, Haruka, Ogusa, Eriko, Ishii, Yoshimi, Miyashita, Kazuho, Motohashi, Kenji, Miyazaki, Takuya, Tachibana, Takayoshi, Hagihara, Maki, Matsumoto, Kenji, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Fujita, Hiroyuki, Kanamori, Heiwa, Yamazaki, Etsuko, Nakajima, Hideaki

“…We hypothesized that treatment-related weight loss is associated with worse outcomes following HSCT. Overall, 184 patients with AML who underwent induction…”
Get full text

The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation by Shimazu, Yutaka, Murata, Makoto, Kondo, Takeshi, Minami, Yosuke, Tachibana, Takayoshi, Doki, Noriko, Uchida, Naoyuki, Ozawa, Yukiyasu, Yano, Shingo, Fukuda, Takahiro, Kato, Jun, Ara, Takahide, Eto, Testuya, Ishikawa, Jun, Nakamae, Hirohisa, Tanaka, Junji, Ichinohe, Tatsuo, Atsuta, Yoshiko, Nagamura‐Inoue, Tokiko

“…The introduction of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) treatment has dramatically improved the prognosis of CML patients and…”
Get full text

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation by Ando, Taiki, Tachibana, Takayoshi, Tanaka, Masatsugu, Suzuki, Taisei, Ishiyama, Yasufumi, Koyama, Satoshi, Ogusa, Eriko, Numata, Ayumi, Matsumoto, Kenji, Kanamori, Heiwa, Nakajima, Hideaki

“…We evaluated the kinetics of immune reconstitution (IR) after allogeneic hematopoietic cell transplantation (HSCT) and analyzed the clinical effect of IR on…”
Get full text

The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation by Tachibana, Takayoshi, Najima, Yuho, Akahoshi, Yu, Hirabayashi, Shigeki, Harada, Kaito, Doki, Noriko, Uchida, Naoyuki, Fukuda, Takahiro, Sawa, Masashi, Ogata, Masao, Takada, Satoru, Tanaka, Masatsugu, Matsuhashi, Yoshiko, Tanaka, Junji, Onizuka, Makoto, Ichinohe, Tatsuo, Atsuta, Yoshiko, Kako, Shinichi

“…The prognostic impacts of BCR-ABL1 fusion gene mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) remain unknown. Using data…”
Get full text

Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera by Tachibana, Takayoshi, Nakayama, Naoki, Matsumura, Ayako, Nakajima, Yuki, Takahashi, Hiroyuki, Miyazaki, Takuya, Nakajima, Hideaki

“…A 65-year-old man was diagnosed with polycythemia vera (PV) and treated with hydroxyurea. Three years later, he was admitted to our institution for severe…”
Get full text

The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation by Harada, Kaito, Tachibana, Takayoshi, Ohashi, Kazuteru, Ozawa, Yukiyasu, Sawa, Masashi, Kondo, Tadakazu, Ishikawa, Jun, Onizuka, Makoto, Imada, Kazunori, Fujisaki, Tomoaki, Tanaka, Junji, Fukuda, Takahiro, Atsuta, Yoshiko, Kako, Shinichi

“…To evaluate the prognostic impact of melphalan dose and total body irradiation (TBI) in acute lymphoblastic leukemia (ALL) patients undergoing…”
Get full text